It has been reported that a histone deacetylase (HDAC) inhibitor, which increases histone acetylation modifications in combination with DNA demethylating agents, acts in a coordinated manner to induce the expression of silenced cancer suppressor genes [6,7,8,9]. The gene discussed is HDAC9; the disease is cancer.